z-logo
open-access-imgOpen Access
Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]
Author(s) -
Louis M. Pelus,
Jonathan Hoggatt,
Tiffany Tate
Publication year - 2015
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s87133
Subject(s) - biosimilar , pegfilgrastim , filgrastim , neutropenia , pharmacokinetics , medicine , chemotherapy , pharmacology , oncology , intensive care medicine

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom